Manufacturing & CDMO
- Pore geometry and packaging risk before a production run
- A failed titer is a late place to learn the constriction
- Serotype and mutant panels on the same measurement
Who it's for
The same structure-derived read serves manufacturing yield and capsid engineering, before material is committed.
The shell
Spyndle Bio is a computational platform for gene therapy capsids. It resolves the five-fold pore of a serotype or mutant so the decision to build, screen, or scale rests on structure.
Spyndle Bio
Computational biochemistry, biophysics, and agentic systems applied to AAV capsid decisions.
Chief Scientific Officer
Cheminformatics and medicinal chemistry researcher pursuing a PhD at the University of Melbourne (MSc Biotechnology, Swinburne). Published in mechanism-encoded SAR, chemical space topology, and ligand optimisation across Cambridge, NUS, MIPS, and Melbourne collaborations.
Co-Founder · Lead Research Engineer
Foundational AI researcher with expertise in AI agents, computational biochemistry, and quantum computing. Builds AI-driven systems and data-intensive applications for biotech and drug discovery, including knowledge graphs and molecular dynamics.
Lead Biochemist
Computational chemistry graduate with experience in protein dynamics, machine learning, structural biology, and drug design. Applies computational approaches to complex biological systems.
Lead Biophysicist
Computational mathematics graduate from the University of Colombo with experience in quantum computing, molecular simulations, protein–ligand modeling, and scientific computing.